{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:20Z","timestamp":1791489680198,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":271,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101460","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:52:57Z","timestamp":1791341577000},"page":"101460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pretreatment lactate dehydrogenase, but not magnesium or neutrophil-to-lymphocyte ratio, is independently associated with grade \u22653 chemotherapy toxicity in breast cancer: prediction-model development and internal validation in 400 patients"],"prefix":"10.1016","volume":"49","author":[{"given":"Shwan Ramadhan","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-7167","authenticated-orcid":false,"given":"Dlzar Dlshad","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101460_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.ctarc.2026.101460_bib0002","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","article-title":"Priorities for cancer research in low- and middle-income countries: a global perspective","volume":"28","author":"Pramesh","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101460_bib0003","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101460_bib0004","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the CRASH score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2026.101460_bib0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1200\/JCO.20.02063","article-title":"Development and validation of a risk tool for predicting severe toxicity in older adults receiving chemotherapy for early-stage breast cancer","volume":"39","author":"Magnuson","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101460_bib0006","first-page":"85","article-title":"Predictive value of the Cancer and Aging Research Group Score for chemotherapy toxicities in older adults with cancer: a systematic review and meta-analysis","volume":"34","author":"Horiuchi","year":"2026","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctarc.2026.101460_bib0007","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijsu.2010.05.012","article-title":"Age at diagnosis of breast cancer in Arab nations","volume":"8","author":"Najjar","year":"2010","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ctarc.2026.101460_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71927-6","article-title":"Machine learning improves the prediction of febrile neutropenia in Korean inpatients undergoing chemotherapy for breast cancer","volume":"10","author":"Cho","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101460_bib0009","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.ctarc.2026.101460_bib0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.34067\/KID.0005622020","article-title":"Rondon-Berrios H. Hypomagnesemia in the cancer patient","volume":"2","author":"Workeneh","year":"2021","journal-title":"Kidney360"},{"key":"10.1016\/j.ctarc.2026.101460_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ctarc.2026.101460_bib0012","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ctarc.2026.101460_bib0013","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: part II - binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat. Med."},{"key":"10.1016\/j.ctarc.2026.101460_bib0014","unstructured":"National Cancer Institute. Common terminology Criteria for adverse events (CTCAE), version 5.0. Bethesda, MD: national Cancer Institute; 2017."},{"key":"10.1016\/j.ctarc.2026.101460_bib0015","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ctarc.2026.101460_bib0016","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1093\/oncolo\/oyad050","article-title":"External validity of two scores for predicting the risk of chemotherapy toxicity among older patients with solid tumors: results from the ELCAPA prospective cohort","volume":"28","author":"Frelaut","year":"2023","journal-title":"Oncologist"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:43:17Z","timestamp":1791488597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"alternative-id":["S2468294226003709"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101460","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment lactate dehydrogenase, but not magnesium or neutrophil-to-lymphocyte ratio, is independently associated with grade \u22653 chemotherapy toxicity in breast cancer: prediction-model development and internal validation in 400 patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101460"}}